Literature DB >> 30412859

Development of disease and immunity at the genital epithelium following intrarectal inoculation of male guinea pigs with herpes simplex virus type 2.

Nigel Bourne1, Brianne N Banasik2, Clarice L Perry2, Aaron L Miller2, Mellodee White2, Richard B Pyles1, Gregg N Milligan3.   

Abstract

Most analyses of genital immunity to herpes simplex virus type 2 (HSV-2) have been performed in females, consequently immune protection of the male genital epithelium is incompletely understood. We developed a model of male genital HSV-2 infection resulting from intrarectal inoculation of guinea pigs. Vesicular lesions developed transiently on the perineum and foreskin concurrent with acute virus shedding. Virus shedding and recurrent genital lesions were also detected after establishment of a latent infection. Analysis of perineum and foreskin RNA detected transcripts for IFNγ, proinflammatory and regulatory cytokines, and for genes involved in migration and regulation of leukocytes. HSV-specific T cells were detected in lymphoid and genital tissues after resolution of the primary infection whereas virus-specific antibody secreting cells were detected only in lymphoid tissue. Taken together, the ability to quantify pathogenesis and local immunity in this guinea pig model represent an important advance towards understanding immunity to HSV-2 in males.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Foreskin; Gene expression; HSV-2; IFNγ; Male guinea pig; Microarray; Perineum

Mesh:

Substances:

Year:  2018        PMID: 30412859      PMCID: PMC6289718          DOI: 10.1016/j.virol.2018.10.023

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  47 in total

1.  Genital herpes in guinea-pigs. An experimental model with Herpesvirus hominis.

Authors:  B Lukás; W Wiesendanger; K H Schmidt-Ruppin
Journal:  Arch Gesamte Virusforsch       Date:  1974

2.  Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group.

Authors:  L Corey; A G Langenberg; R Ashley; R E Sekulovich; A E Izu; J M Douglas; H H Handsfield; T Warren; L Marr; S Tyring; R DiCarlo; A A Adimora; P Leone; C L Dekker; R L Burke; W P Leong; S E Straus
Journal:  JAMA       Date:  1999-07-28       Impact factor: 56.272

3.  Genital infections due to herpes simplex virus type 2 in male guinea pigs.

Authors:  D E Stephanopoulos; M G Myers; D I Bernstein
Journal:  J Infect Dis       Date:  1989-01       Impact factor: 5.226

4.  Herpes simplex virus shedding among human immunodeficiency virus-negative men who have sex with men: site and frequency of shedding.

Authors:  M R Krone; S R Tabet; M Paradise; A Wald; L Corey; C L Celum
Journal:  J Infect Dis       Date:  1998-10       Impact factor: 5.226

5.  Risk of acquisition of genital herpes simplex virus type 2 in sex partners of persons with genital herpes: a prospective couple study.

Authors:  Y Bryson; M Dillon; D I Bernstein; J Radolf; P Zakowski; E Garratty
Journal:  J Infect Dis       Date:  1993-04       Impact factor: 5.226

6.  Risk factors for the sexual transmission of genital herpes.

Authors:  G J Mertz; J Benedetti; R Ashley; S A Selke; L Corey
Journal:  Ann Intern Med       Date:  1992-02-01       Impact factor: 25.391

Review 7.  Genital herpes simplex virus infections: clinical manifestations, course, and complications.

Authors:  L Corey; H G Adams; Z A Brown; K K Holmes
Journal:  Ann Intern Med       Date:  1983-06       Impact factor: 25.391

8.  Use of transcriptional profiling to delineate the initial response of mice to intravaginal herpes simplex virus type 2 infection.

Authors:  Thomas L Cherpes; Stephen A K Harvey; Jaclyn M Phillips; Rodolfo D Vicetti Miguel; Melissa A Melan; Nirk E Quispe Calla; Robert L Hendricks
Journal:  Viral Immunol       Date:  2013-05-02       Impact factor: 2.257

9.  Use of a Guinea pig-specific transcriptome array for evaluation of protective immunity against genital chlamydial infection following intranasal vaccination in Guinea pigs.

Authors:  Shradha Wali; Rishein Gupta; Ronald L Veselenak; Yansong Li; Jieh-Juen Yu; Ashlesh K Murthy; Andrew P Cap; M Neal Guentzel; James P Chambers; Guangming Zhong; Roger G Rank; Richard B Pyles; Bernard P Arulanandam
Journal:  PLoS One       Date:  2014-12-11       Impact factor: 3.240

10.  Global and Regional Estimates of Prevalent and Incident Herpes Simplex Virus Type 1 Infections in 2012.

Authors:  Katharine J Looker; Amalia S Magaret; Margaret T May; Katherine M E Turner; Peter Vickerman; Sami L Gottlieb; Lori M Newman
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

View more
  1 in total

Review 1.  Vaccines to prevent genital herpes.

Authors:  Kevin Egan; Lauren M Hook; Philip LaTourette; Angela Desmond; Sita Awasthi; Harvey M Friedman
Journal:  Transl Res       Date:  2020-03-16       Impact factor: 7.012

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.